только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Раздел 31 / 36
Страница 1 / 1

Список литературы

  1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members; Document Reviewers.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016 Aug;18(8):891-975.
  2. Мареев В. Ю., Фомин И. В., Агеев Ф. Т. и соавт. Клинические рекомендации ОССН – РКО – РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика, профилактика и лечение. Кардиология. 2018;58(S6):8–164.
  3. McMurray J.J., Adamopoulos S., Anker S.D. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J. 2012, Vol. 33: 17871847.
  4. Kristensen S.D., Knuuti J., Saraste A. et al; authors/Task Force Members. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and man- agement: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA) // Eur. Heart. J. — 2014. — Vol. 14. — Suppl. 35. — N 35. — P. 2383-2431.
  5. Kelder JC, Cramer MJ, van Wijngaarden J, van Tooren R, Mosterd A, Moons KGM, Lammers JW, Cowie MR, Grobbee DE, Hoes AW. The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation 2011;124:2865–2873.
  6. Baumgartner H., Falk V., Bax J., De Bonis M. et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease: The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017 Aug 26. doi: 10.1093/eurheartj/ehx391.
  7. Roizen, MF. Anesthestic Implications of Comorbid Diseases. Chapter 35. In: Miller's Anesthesia. 7th Edition, Churchill Livingstone, 2009.
  8. Biccard BM, Lurati Buse GA, Burkhart C, Cuthbertson BH, Filipovic M, Gibson SC et al. The influence of clinical risk factors on pre-operative B-type natriuretic peptide risk stratification of vascular surgical patients. Anaesthesia 2012;67:55–59.
  9. Rajagopalan S, Croal BL, Reeve J, Bachoo P, Brittenden J. N-terminal pro-B-type natriuretic peptide is an independent predictor of all-cause mortality and MACE after major vascular surgery in medium-term follow-up. Eur J Vasc Endovasc Surg 2011;41:657–662.
  10. Rodseth RN, Padayachee L, Biccard BM. A meta-analysis of the utility of preoperative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 2008;63:1226–1233.
  11. Moonesinghe SR, Mythen MG, Das P, Rowan KM, Grocott MP. Risk stratification tools for predicting morbidity and mortality in adult patients undergoing major surgery: qualitative systematic review. Anesthesiology 2013;119:959–981.
  12. Rodseth RN, Biccard BM, Le Manach Y, Sessler DI, Lurati Buse GA, Thabane L et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic Peptide and N-terminal fragment of pro-B-type natriuretic Peptide: a systematic review and individual patient data meta-analysis. J Am Coll Cardiol 2014;63:170 –180.
  13. Jeger RV, Probst C, Arsenic R, Lippuner T, Pfisterer ME, Seeberger MD et al. Longterm prognostic value of the pre-operative 12-lead electrocardiogram before major noncardiac surgery in coronary artery disease. Am Heart J 2006;151: 508–513.
  14. Kazmers A, Cerqueira MD, Zierler RE. Peri-operative and late outcome in patients with left ventricular ejection fraction of 35% or less who require major vascular surgery. J Vasc Surg 1988;8:307–315.
  15. Healy KO,Waksmonski CA, Altman RK, Stetson PD, Reyentovich A, Maurer MS. Perioperative outcomeand long-termmortality for heart failure patients undergoing intermediate- and high-risk noncardiac surgery: impact of left ventricular ejection fraction. Congest Heart Fail 2010;16:45–49.
  16. Juhani Knuuti, William Wijns, Antti Saraste, Davide Capodanno, Emanuele Barbato, Christian Funck-Brentano, Eva Prescott, Robert F Storey, Christi Deaton, Thomas Cuisset, Stefan Agewall, Kenneth Dickstein, Thor Edvardsen, Javier Escaned, Bernard J Gersh, Pavel Svitil, Martine Gilard, David Hasdai, Robert Hatala, Felix Mahfoud, Josep Masip, Claudio Muneretto, Marco Valgimigli, Stephan Achenbach, Jeroen J Bax, ESC Scientific Document Group, 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC), European Heart Journal, Volume 41, Issue 3, 14 January 2020, Pages 407–477, https://doi.org/10.1093/eurheartj/ehz425
  17. Mock MB, Ringqvist I, Fisher LD, Davis KB, Chaitman BR, Kouchoukos NT, Kaiser GC, Alderman E, Ryan TJ, RussellROJr., Mullin S, Fray D, KillipT3rd. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation 1982;66:562–568.
  18. Mark DB, Nelson CL, Califf RM, Harrell FE Jr., Lee KL, Jones RH, FortinDF, Stack RS,Glower DD, Smith LR et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation 1994;89:2015– 2025.
  19. Hammermeister KE, DeRouen TA, Dodge HT. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation 1979;59:421–430.
  20. Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J, Natarajan MK, Horsman C, Fox KA, Yusuf S. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 2009;360:2165–2175.
  21. Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, Stuckey T, Tcheng JE, Mehran R, Lansky AJ, Grines CL, Stone GW. Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol 2010;55:1416–1424.
  22. Boersma E, Primary Coronary Angioplasty vs Thrombolysis Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006;27(7):779–788.
  23. Fleisher L.A., Fleischmann K.E., Auerbach A.D. et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of ardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014; 64(22):e77137. doi: 10.1016/j.jacc.2014.07.944.
  24. Fletcher HR, Milhoan LH, Evans K, Austin PN. Patients with aortic stenosis: who should undergo noncardiac surgery in a rural hospital? J Perianesth Nurs 2013;28: 368– 376.
  25. Upshaw J., Kiernan M.S. Pre-operative cardiac risk assessment for noncardiac surgery in patients with heart failure. Curr Heart Fail Rep 2013;10:147–156
  26. Antoniou GA, Chalmers N, Georgiadis GS, Lazarides MK, Antoniou SA, SerracinoInglott F et al. A meta-analysis of endovascular vs. surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg 2013;57:242–253.
  27. Holte K, Kehlet H. Post-operative ileus: a preventable event. Br J Surg 2000;87:1480– 1493.
  28. Popescu WM, Bell R, Duffy AJ, Katz KH, Perrino AC. A pilot study of patients with clinically severe obesity undergoing laparoscopic surgery: evidence for impaired cardiac performance. J Cardiothorac Vasc Anesth 2011;25:943–949.
  29. Lestar M, Gunnarsson L, Lagerstrand L, Wiklund P, Odeberg-Wernerman S..Hemodynamic perturbations during robot-assisted laparoscopic radical prostatectomyin 458 Trendelenburg position. Anesth Analg 2011;113:1069–1075.
  30. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, ElAllaf D, Vı´tovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Ja´nosi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P. MERIT-HF Study Group. Effects of controlled-release metoprolol on total mortality, hospitalizations, and wellbeing in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive Heart Failure (MERIT-HF). JAMA 2000;283:1295–1302.
  31. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651–1658.
  32. Jong P, Yusuf S, Rousseau MF, Ahn SA, Bangdiwala SI. Effect of enalapril on 12yearsurvival and life expectancy in patients with left ventricular systolic dysfunction: afollow-up study. Lancet 2003;361:1843–1848.
  33. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. NEngl J Med 2014;371:993–1004
  34. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC et al. Effects of xtendedrelease metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839–1847.
  35. Rosenman DJ, McDonald FS, Ebbert JO, Erwin PJ, LaBella M, Montori VM. Clinical consequences of withholding vs. administering renin-angiotensin-aldosterone system antagonists in the pre-operative period. J Hosp Med 2008;3:319–325.
  36. Zannad F, McMurray JJV, Krum H, Van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011;364:11–21.
  37. Faris RF, Flather M, Purcell H, Poole-Wilson PA, Coats AJ. Diuretics for heart failure. Cochrane Database Syst Rev 2012;2:CD003838.
  38. King JB, Bress AP, Reese AD, Munger MA. Neprilysin inhibition in heart failure with reduced ejection fraction: a clinical review. Pharmacother J Hum Pharmacol Drug Ther 2015;35:823–837.
  39. Mangiafico S, Costello-Boerrigter LC, Andersen IA, Cataliotti A, Burnett JC. Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics. Eur Heart J 2013;34:886–893.
  40. Homma S, Thompson JLP, Pullicino PM et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 2012; 366:1859–1869.
  41. Lip GYH, Ponikowski P, Andreotti F et al. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Eur J Heart Fail 2012;14:681–695.
  42. Pengo V, Cucchini U, Denas G, Erba N, Guazzaloca G, La Rosa L et al. Standardized Low-Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery An Inception Cohort Management Study. Circulation 2009;119:2920–2927.
  43. Заболотских И.Б., Киров М.Ю., Божкова С.А., Буланов А.Ю., Воробьева Н.А., Григорьев Е.В., Грицан А.И., Курапеев И.С., Лебединский К.М., Ломиворотов В.В., Овечкин А.М., Потиевская В.И., Синьков С.В., Субботин В.В., Шулутко Е.М., Лубнин А.Ю. Периоперационное ведение больных, получающих длительную антитромботическую терапию. // Анестезиология и реаниматология. 2014. № 4. С. 4-14.
  44. Toller W., Algotsson L., Guarracino F. et al. Perioperative use of levosimendan: best practice in operative settings.J Cardiothorac Vasc Anesth 2013, 27: 361-366.
  45. Landoni G, Biondi-Zoccai G, Greco M et al. Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies. Crit Care Med. 2012 Feb;40(2):634-46. doi: 10.1097/CCM.0b013e318232962a.
  46. Лихванцев В.В., Марченко Д.Н., Гребенчиков О.А. и соавт.Профилактика сердечной недостаточности в сосудистой хирургии у пациентов со сниженной фракцией изгнания левого желудочка: левосимендан или анестетическая кардиопротекция? Анестезиология и реаниматология. 2016. Т. 61. № 6. С. 411-417.
  47. Ponschab M., Hochmair N., Ghazwinian N. et al. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair. Eur. J. Anaesthesiol. 2008; 25 (8): 627-33.
  48. Корниенко А. Н., Добрушина О. Р., Зинина Е. П. Профилактика кардиальных осложнений внесердечных операций. Общ. реаниматол. -2011. -Т. VII, № 5. -C. 5766.
  49. Хороненко В.Э., Мандрыка Е.А., Баскаков Д.С., Суворин П.А. Адъювантная кардиопротекция в торакальной онкохирургии. Анестезиология и реаниматология. 2019;1:35-43. https://doi.org/10.17116/anaesthesiology201901135
  50. Xiao-Guang Y, Xia-Guang D, Yu-Ging K.China. The study of myocardial protective effect of creatine phosphate sodium in liver transplant patients. Journal of Modern Medicine, 2013,19:76-78
  51. Wen-Long Z, Meng-Fei Y. The myocardial protective effect of sodium phosphocreatine on elderly patients with hip replacement operation. Chinese Journal of Gerontology, 2012,32(2):398-399
  52. Landoni G, Zangrillo A, Lomivorotov VV, Likhvantsev V, Ma J, De Simone F, Fominskiy E. Cardiac protection with phosphocreatine: a meta-analysis. Interactive Cardiovascular and Thoracic Surgery. 2016;23:637-647. https://doi.org/10.1093/icvts/ivw171
  53. Дербугов В.Н., Потапов А.Л., Потиевская В.И., Хмелевский Я.М. Применение экзогенного фосфокреатина у пациентов пожилого и старческого возраста, оперируемых по поводу колоректального рака. Общая реаниматология. 2017;13(4):38-45. DOI:10.15360/1813-9779-2017-4-38-45
  54. Landoni G., Fochi O., Bignami E. et al. Cardiac protection by volatile anesthetics in non-cardiac surgery? A metaanalysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care CardiovascAnesth. 2009;1:34-43.
  55. Pagel P.S., Farber N.E., Wedel D.J. Cardiovascular Pharmacology // In: Мiller’sAnaesthesia. Ed. Miller R.D., 2005.
  56. Pirracchio R., Cholley B., De Hert S., Cohen Solal A. and Mebazaa A. Diastolic heart failure in anaesthesia and critical care. Br. J. Anaesth. (2007) 98 (6): 707-721.
  57. Rodgers A., Walker N., Schug S. et al. Reduction of post-operative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 2000;321: 1493–1497.
  58. Guay J., Choi P., Suresh S. et al. Neuraxial blockade for the prevention of post-operative mortality and major morbidity: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev 2014;1:CD010108.
  59. Sakaguchi T1, Hirata A2, Kashiwase K3, Higuchi Y2, Ohtani T4, Sakata Y4, Yasumura Y5.Relationship of Central Venous Pressure to Body Fluid Volume Status and Its Prognostic Implication in Patients With Acute Decompensated Heart Failure. J Card Fail. 2018 Jun 9. pii: S1071-9164(18)30209-4.
  60. Iacoviello M, Puzzovivo A, Monitillo F, Saulle D, Lattarulo MS, Guida P, Forleo C, Gesualdo L, Favale S.Independent role of high central venous pressure in predicting worsening of renal function in chronic heart failure outpatients. Int J Cardiol. 2013 Jan 20;162(3):261-3. doi: 10.1016/j.ijcard.2012.06.088. Epub 2012 Jul 16.
  61. Mohamedali B1, Doukky R2, Karavalos K3, Avery E3, Bhat G4.Mean Arterial Pressure to Central Venous Pressure Ratio: A Novel Marker for Right Ventricular Failure After Left Ventricular Assist Device Placement. J Card Fail. 2017 Jun;23(6):446-452. doi: 10.1016/j.cardfail.2017.03.009. Epub 2017 Mar 29.
  62. van Diepen S, Bakal JA, McAlister FA, Ezekowitz JA. Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients. Circulation 2011; 124:289–296
  63. Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003;348:5-14.
  64. Mueller H., Chatterjee K., Davis K. et al. Present use of bedside right heart catheterization in patients with cardiac disease. JACC. 1998; 32 (3): 840–864.
  65. Memtsoudis SG, Rosenberger P, Loffler M, et al. The usefulness of ransesophageal echocardiography during intraoperative cardiac arrest in noncardiac surgery. Anesth Analg. 2006;102:1653-7.
  66. Shillcutt SK, Markin NW, Montzingo CR, et al. Use of rapid "rescue" perioperative echocardiography to improve outcomes after hemodynamic instability in noncardiac surgical patients. J Cardiothorac Vasc Anesth. 2012;26:362-70.
  67. Pöpping D.M., Elia N., Van Aken H.K. et al. Impact of epidural analgesia on mortality and morbidity after surgery: systematic review and meta-analysis of randomized controlled trials. Ann Surg. 2014 259(6):1056-67. doi: 10.1097/SLA.0000000000000237.
  68. Nishimori M., Low J.H.S,. Zheng H. et al. Epidural pain relief versus systemic opioidbased pain relief for abdominal aortic surgery. Cochrane Database Syst Rev. 2012;7:CD005059.
  69. Frank SM, Fleisher LA, Breslow MJ, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA. 1997;277:1127-34.
  70. Karalapillai D, Story D, Hart GK, et al. Postoperative hypothermia and patient outcomes after major elective noncardiac surgery. Anaesthesia. 2013;68:605-11.
  71. Wang CS. Does This Dyspneic Patient in the Emergency Department Have Congestive Heart Failure? JAMA. 2005;294 (15):1944.
  72. Баутин А.Е., Осовских В.В., Басова В.А. Эхокардиографический мониторинг. В кн. Кровообращение и анестезия. Под ред. Лебединского К.М. – СПб: «Человек», 2012.- С. 365-398.
  73. Seidlerová J, Tůmová P, Rokyta R, Hromadka M. Factors influencing the accuracy of non-invasive blood pressure measurements in patients admitted for cardiogenic shock. BMC Cardiovasc Disord. 2019 Jun 18;19(1):150. doi: 10.1186/s12872-019-1129-9. PMID: 31215405; PMCID: PMC6582540.
  74. Green EM, Givertz MM. Management of acute right ventricular failure in theintensive care unit. Curr Heart Fail Rep 2012;9:228 –235
  75. Schumann J., Henrich E.C., Strobl H. et al. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev. 2018 Jan 29;1:
  76. Готье С. В., Попцов В. Н., Захаревич В. М., Шевченко А. О., Спирина Е.А., Ухренков С.Г. и др. Пятилетний опыт применения периферической веноартериальной экстракорпоральной мембранной оксигенации как метода механической поддержки кровообращения у потенциальных реципиентов сердца. Вестник трансплантологии и искусственных органов. 2016;18 (4):16–25. [Gautier S. V., Poptsov V. N., Zakharevich V. M., Shevchenko A. O., Spirina E.A., Ukhrenkov S. G. et al. Five-year experience in peripheral venoarterial extracorporeal membrane oxygenation as a method of mechanical circulatory support in potential heart transplant recipients. Russian Journal of Transplantology and Artificial Organs. 2016;18 (4):16–25.] DOI:10.1582 5/1995-1191-2016-4-16-32.
  77. Estep JD, Starling RC, Horstmanshof DA, Milano CA, Selzman CH, Shah KB et al. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients. Journal of the American College of Cardiology. 2015;66 (16):1747–61. DOI:10.1016/j. jacc. 2015.07.075.
  78. Thiele H, Zeymer U, Neumann F-J, Ferenc M, Olbrich H-G, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Bo¨hm M, Ebelt H, Schneider S, Schuler G, Werdan K. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012;367:1287–1296.
  79. Sharon A, Shpirer I, Kaluski E, Moshkovitz Y, Milovanov O, Polak R, Blatt A,Simovitz A, Shaham O, Faigenberg Z, Metzger M, Stav D, Yogev R, Golik A, Krakover R, Vered Z, Cotter G. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. J Am Coll Cardiol 2000;36:832–837.
  80. Wakai A, McCabe A, Kidney R, Brooks SC, Seupaul RA, Diercks DB, Salter N, Fermann GJ, Pospisil C. Nitrates for acute heart failure syndromes. Cochrane Database Syst Rev 2013;8:CD005151.
  81. Rawles JM, Kenmure AC. Controlled trial of oxygen in uncomplicated myocardial infarction. Br Med J 1976;1:1121–1123.
  82. Park JH, Balmain S, Berry C, Morton JJ, McMurray JJV. Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction. Heart 2010;96:533–53.
  83. Weng C-L, Zhao Y-T, Liu Q-H, Fu C-J, Sun F, Ma Y-L, Chen Y-W, He Q-Y. Metaanalysis: noninvasive ventilation in acute cardiogenic pulmonary edema.Ann Intern Med 2010;152:590–600.
  84. Gray AJ, Goodacre S, Newby DE, Masson MA, Sampson F, Dixon S, Crane S, Elliott M, Nicholl J. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO Trial. Health Technol Assess 2009;13:1–106.